BiotechTube

V205C, measles, mumps, and rubella virus vaccine live + Comparator: Measles, Mumps, and Rubella Virus Vaccine Live

Phase 2Completed
0 watching 0 views this week⚡ Active
52
Hype Score

Development Stage

✓
Pre-clinical
✓
Phase 1
3
Phase 2
4
Phase 3
5
Approved
Indication / Disease

Measles

Conditions

Measles

Trial Timeline

Oct 1, 2004 → May 1, 2005

NCT ID
NCT00109278

About V205C, measles, mumps, and rubella virus vaccine live + Comparator: Measles, Mumps, and Rubella Virus Vaccine Live

V205C, measles, mumps, and rubella virus vaccine live + Comparator: Measles, Mumps, and Rubella Virus Vaccine Live is a phase 2 stage product being developed by Merck for Measles. The current trial status is completed. This product is registered under clinical trial identifier NCT00109278. Target conditions include Measles.

Hype Score Breakdown

Clinical
17
Activity
12
Company
10
Novelty
5
Community
5

Clinical Trials (1)

NCT IDPhaseStatus
NCT00109278Phase 2Completed

Competing Products

20 competing products in Measles

See all competitors
ProductCompanyStageHype Score
Measles-Rubella vaccine (Live) I.P. (Freeze Dried) of M/s. Zydus Lifesciences Ltd + Yellow fever Vaccine (WHO prequalified)Zydus LifesciencesPhase 3
77
MMRV (AMP) + MMRV (2006 process)MerckPhase 3
77
M-M-R™II manufactured with recombinant Human Albumin (rHA) and VARIVAX®MerckPhase 3
77
Measles, Mumps, Rubella and Varicella (Oka-Merck) Virus Vaccine Live (ProQuad™) + M-M-R™ II and Varivax™MerckPhase 3
77
Measles, Mumps, Rubella and Varicella (Oka-Merck) Virus Vaccine Live + Comparator: M-M-R II + Comparator: PUVVMerckPhase 2
52
Measles, Mumps, Rubella and Varicella (Oka-Merck) Virus Vaccine Live + Comparator: Varivax + Comparator: M-M-R IIMerckPhase 3
77
ProQuad® manufactured with recombinant Human Albumin (rHA)MerckPhase 3
77
Comparator: M-M-R(TM) II, measles, mumps, and rubella virus vaccine live + Comparator: VARIVAX(TM) Varicella Virus Vaccine Live (Oka-Merck)MerckPhase 3
77
measles, mumps, and rubella virus vaccine live + Comparator: Measles, Mumps, and Rubella Virus Vaccine LiveMerckPhase 2
52
Measles, Mumps, Rubella and Varicella (Oka-Merck) Virus Vaccine Live + Comparator: Tripedia + Comparator: Comvax + Comparator: Varivax + Comparator: M-M-R IIMerckPhase 3
77
V221, measles, mumps, rubella and varicella (Oka/Merck) virus vaccine live / Duration of Treatment: 12 weeksMerckPhase 3
77
Comparator: ProQuad™ (V221) + Comparator: PREVNAR™ (pneumococcal 7-valent conjugate vaccine)MerckPhase 3
77
Measles, Mumps, Rubella and Varicella (Oka-Merck) Virus Vaccine Live + Comparator: Placebo + Comparator: Varivax + Comparator: M-M-R IIMerckPhase 3
77
ProQuad®MerckPhase 3
77
MMR vaccineMerckPre-clinical
23
ProQuad®MerckPhase 3
77
ProQuad (Measles, Mumps, Rubella and Varicella (Oka-Merck) Virus Vaccine Live) + Comparator: M-M-R II + Comparator: Varivax + Comparator: PlaceboMerckPhase 3
77
Measles vaccineNovo NordiskApproved
84
Measles vaccineNovo NordiskApproved
84
Measles vaccineNovo NordiskApproved
84

Other Products from Merck

DuleraApproved
85
ImipenemApproved
85
Mavenclad®Approved
85
raltegravir + PlaceboApproved
85
alendronate sodiumApproved
85